5-HT3 antagonist

Results: 136



#Item
51PALLIATIVE CARE CASE OF THE MONTH “Second-Line Anti-emetic Therapies for Refractory Chemotherapy-Induced Nausea and Vomiting” Helen Dorra, MD Volume 14, No. 37

PALLIATIVE CARE CASE OF THE MONTH “Second-Line Anti-emetic Therapies for Refractory Chemotherapy-Induced Nausea and Vomiting” Helen Dorra, MD Volume 14, No. 37

Add to Reading List

Source URL: www.dom.pitt.edu

Language: English - Date: 2014-06-23 15:08:50
52VOLUME 29 䡠 NUMBER 31 䡠 NOVEMBER[removed]JOURNAL OF CLINICAL ONCOLOGY A S C O

VOLUME 29 䡠 NUMBER 31 䡠 NOVEMBER[removed]JOURNAL OF CLINICAL ONCOLOGY A S C O

Add to Reading List

Source URL: jco.ascopubs.org

Language: English
53MEMORANDUM  DEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION AND RESEARCH

MEMORANDUM DEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION AND RESEARCH

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2006-11-13 08:05:23
54http://www.fda.gov/cder/foi/esum/2005/20007s035_ZOFRAN_CLINICAL_BPCA.pdf

http://www.fda.gov/cder/foi/esum/2005/20007s035_ZOFRAN_CLINICAL_BPCA.pdf

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2006-11-13 08:05:24
55Hospira Issues A Voluntary Nationwide Recall of One Lot of Metoclopramide Injection, USP, and two lots of ondansetron injection, USP, due to Glass (Glass Strands) particulate caused  by glass supplier defect

Hospira Issues A Voluntary Nationwide Recall of One Lot of Metoclopramide Injection, USP, and two lots of ondansetron injection, USP, due to Glass (Glass Strands) particulate caused by glass supplier defect

Add to Reading List

Source URL: www.hospira.com

Language: English - Date: 2014-11-25 12:02:47
5620239S023 Granisetron Clinical PREA

20239S023 Granisetron Clinical PREA

Add to Reading List

Source URL: www.fda.gov

Language: English
57Division: Pharmacy Services  Subject: Prior Authorization Criteria Original Development Date: Original Effective Date:

Division: Pharmacy Services Subject: Prior Authorization Criteria Original Development Date: Original Effective Date:

Add to Reading List

Source URL: www.ahca.myflorida.com

Language: English - Date: 2012-10-08 11:24:29
58Microsoft Word - NAE Final.doc

Microsoft Word - NAE Final.doc

Add to Reading List

Source URL: www.oregon.gov

Language: English - Date: 2014-07-15 14:00:34
59HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ZOFRAN safely and effectively. See full prescribing information for ZOFRAN. ZOFRAN® (ondansetron hydrochloride) inj

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ZOFRAN safely and effectively. See full prescribing information for ZOFRAN. ZOFRAN® (ondansetron hydrochloride) inj

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2011-09-16 15:10:36
60Microsoft Word - BURN SO[removed]doc

Microsoft Word - BURN SO[removed]doc

Add to Reading List

Source URL: saems.net

Language: English - Date: 2013-11-04 18:32:37